5-Formyl-2,4-dimethylpyrrole-3-carboxylic acid

GTC-179

Pharmaceutical Intermediates

5-Formyl-2,4-dimethylpyrrole-3-carboxylic acid

CAS No.
253870-02-9
Catalogue ID
GTC-179

5-Formyl-2,4-dimethylpyrrole-3-carboxylic acid, CAS 253870-02-9. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

2,4-Dimethyl-5-formyl-1H-pyrrole-3-carboxylic acid; 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid; 1H-Pyrrole-3-carboxylic acid, 5-formyl-2,4-dimethyl-; 5-Formyl-2,4-dimethyl-3-pyrrolecarboxylic acid; 2,4-Dimethyl-5-formylpyrrole-3-carboxylic acid

Supplied catalogue source: GTC-179 · Page 98

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.

5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid is a functionalized pyrrole derivative featuring both aldehyde and carboxylic acid groups. This dual functionality makes it highly useful for condensation and amidation reactions in controlled synthetic sequences.


Basic Information

CAS No.253870-02-9
EC No.607-716-8
Linear FormulaC8H9NO3
Molecular Weight167.16
AppearanceYellow crystalline powder
Melting Point283 °C (lit.)
Boiling point374.9±42.0 °C (Predicted)
Density1.342±0.06 g/cm³ (Predicted)
SolubilitySlightly soluble in DMSO, methanol, and aqueous base (typical reference)
Storage ConditionsKeep in dark place, sealed in dry, room temperature
Chemical StructureMolecular Structure of 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid

Key Applications

  • Pharmaceutical intermediate: An essential building block in the multi-step synthesis of sunitinib, a multi-kinase inhibitor used in oncology, and a relevant component within Gefitinib, Sunitinib and Sorafenib intermediates for targeted therapy development.

  • API intermediate: Employed in the manufacture of active pharmaceutical ingredients targeting receptor tyrosine kinases, especially in the broader category of oncology drug intermediates used for anticancer API synthesis.

  • Heterocyclic synthesis: Provides a versatile pyrrole core for constructing substituted nitrogen-containing aromatic frameworks used in pharmaceutical intermediate design and optimization.

  • Laboratory research: Utilized in medicinal chemistry programs for exploring novel kinase inhibitor analogs and related oncology-focused small molecules.

  • Process development: Applied in route scouting, optimization, and scale-up studies for fine chemical production and pharmaceutical intermediates for API synthesis.


  • Consistent product quality: High purity levels and batch-to-batch uniformity verified through standard analytical methods suitable for pharmaceutical intermediate use.

  • Flexible global supply: Stable export arrangements with established logistics supporting laboratory, pilot, and production-scale quantities.

  • SDS and COA support: Full safety data sheets and certificates of analysis provided promptly for compliance and quality assurance.

  • Packaging and technical service: Flexible options including 1kg, 5kg, or 25kg fiber drums with PE liners together with responsive technical assistance.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY